Sonova Holding (OTCMKTS:SONVY - Get Free Report) saw a large growth in short interest in the month of March. As of March 13th, there was short interest totaling 11,701 shares, a growth of 1,008.0% from the February 26th total of 1,056 shares. Based on an average daily trading volume, of 96,203 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company's shares are short sold. Currently, 0.0% of the company's shares are short sold. Based on an average daily trading volume, of 96,203 shares, the short-interest ratio is presently 0.1 days.
Wall Street Analyst Weigh In
Several research firms have commented on SONVY. Zacks Research raised shares of Sonova from a "strong sell" rating to a "hold" rating in a research note on Monday, February 9th. BNP Paribas Exane raised shares of Sonova from a "strong sell" rating to a "strong-buy" rating in a research note on Tuesday, March 10th. Finally, Jefferies Financial Group lowered shares of Sonova from a "hold" rating to a "moderate sell" rating in a report on Wednesday, March 18th. Two equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Sonova has a consensus rating of "Moderate Buy".
View Our Latest Analysis on Sonova
Sonova Stock Up 0.9%
Sonova stock traded up $0.38 during trading hours on Tuesday, hitting $43.29. The company had a trading volume of 93,868 shares, compared to its average volume of 49,630. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. The company has a 50-day moving average price of $51.58 and a two-hundred day moving average price of $52.98. Sonova has a 1 year low of $42.26 and a 1 year high of $68.76.
About Sonova
(
Get Free Report)
Sonova AG OTCMKTS: SONVY is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.
Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.